Michael D. Becker

Authored Items
December 2017 Vol 3 No 6
“As the CEO of a biotechnology company involved in cancer drugs development, I was familiar with the diagnosis and treatment of patients with cancer,” says Michael Becker, who was himself diagnosed with stage IV oropharyngeal cancer.
Last modified: October 14, 2020